中华整形外科杂志
中華整形外科雜誌
중화정형외과잡지
CHINESE JOURNAL OF PLASTIC SURGERY
2010年
1期
57-60
,共4页
刘宏伟%程飚%吴姮君%顾永峰%陈炫%陈志刚%刘文忠
劉宏偉%程飚%吳姮君%顧永峰%陳炫%陳誌剛%劉文忠
류굉위%정표%오항군%고영봉%진현%진지강%류문충
血管紧张素Ⅱ%瘢痕,肥大性%成纤维细胞%磷脂酰肌醇-3激酶
血管緊張素Ⅱ%瘢痕,肥大性%成纖維細胞%燐脂酰肌醇-3激酶
혈관긴장소Ⅱ%반흔,비대성%성섬유세포%린지선기순-3격매
Angiotensin Ⅱ%Cicatrix,hypertrophic%Fibroblast%Phosphatidylinositol-3kinase
目的 观察血管紧张素Ⅱ(angiotensin Ⅱ,Ang Ⅱ)对增生性瘢痕成纤维细胞磷脂酰肌醇-3激酶/蛋白激酶B(phosphoinositide 3-kinase/Akt,PI3K/Akt)信号通路的影响.方法 体外培养人增生性瘢痕成纤维细胞,用免疫荧光组织化学染色检测细胞Ang Ⅱ受体AT,和AT_2的表达.以PI3k活性测定法和Western Blotting法检测细胞PI3K的活性和Akt的磷酸化.结果 免疫荧光组织化学染色结果显示培养的增生性瘢痕成纤维细胞同表达AT_1和AT_2受体.Ang Ⅱ(10~(-9)~10~(-7)mol/L)刺激可增加细胞Akt的磷酸化和P13K的活性.AT_2受体拮抗剂PD1233191可显著增强AngⅡ诱导的细胞Akt磷酸化和PDK活性增加(P<0.05);AT_1受体拮抗剂Valsartan可显著抑制AngⅡ诱导的细胞Akt磷酸化和PDK活性增加(P<0.05).结论 Ang Ⅱ通过其受体AT_1和AT_2可调控增生性瘢痕成纤维细胞Akt磷酸化和PI3K的活性.
目的 觀察血管緊張素Ⅱ(angiotensin Ⅱ,Ang Ⅱ)對增生性瘢痕成纖維細胞燐脂酰肌醇-3激酶/蛋白激酶B(phosphoinositide 3-kinase/Akt,PI3K/Akt)信號通路的影響.方法 體外培養人增生性瘢痕成纖維細胞,用免疫熒光組織化學染色檢測細胞Ang Ⅱ受體AT,和AT_2的錶達.以PI3k活性測定法和Western Blotting法檢測細胞PI3K的活性和Akt的燐痠化.結果 免疫熒光組織化學染色結果顯示培養的增生性瘢痕成纖維細胞同錶達AT_1和AT_2受體.Ang Ⅱ(10~(-9)~10~(-7)mol/L)刺激可增加細胞Akt的燐痠化和P13K的活性.AT_2受體拮抗劑PD1233191可顯著增彊AngⅡ誘導的細胞Akt燐痠化和PDK活性增加(P<0.05);AT_1受體拮抗劑Valsartan可顯著抑製AngⅡ誘導的細胞Akt燐痠化和PDK活性增加(P<0.05).結論 Ang Ⅱ通過其受體AT_1和AT_2可調控增生性瘢痕成纖維細胞Akt燐痠化和PI3K的活性.
목적 관찰혈관긴장소Ⅱ(angiotensin Ⅱ,Ang Ⅱ)대증생성반흔성섬유세포린지선기순-3격매/단백격매B(phosphoinositide 3-kinase/Akt,PI3K/Akt)신호통로적영향.방법 체외배양인증생성반흔성섬유세포,용면역형광조직화학염색검측세포Ang Ⅱ수체AT,화AT_2적표체.이PI3k활성측정법화Western Blotting법검측세포PI3K적활성화Akt적린산화.결과 면역형광조직화학염색결과현시배양적증생성반흔성섬유세포동표체AT_1화AT_2수체.Ang Ⅱ(10~(-9)~10~(-7)mol/L)자격가증가세포Akt적린산화화P13K적활성.AT_2수체길항제PD1233191가현저증강AngⅡ유도적세포Akt린산화화PDK활성증가(P<0.05);AT_1수체길항제Valsartan가현저억제AngⅡ유도적세포Akt린산화화PDK활성증가(P<0.05).결론 Ang Ⅱ통과기수체AT_1화AT_2가조공증생성반흔성섬유세포Akt린산화화PI3K적활성.
Objective To study the effect of angiotensin Ⅱ on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars. Methods The expression of AT_1 and AT_2 receptor was detected by immunofluorescence staining. Cultured human skin fibroblasts were treated with Ang Ⅱ (10~(-9)-10~(-7)mol/L), with or without an AT_1 receptor blocker, valsartan or an AT_2 receptor antagonist, PD123319. The phosphorylation of Akt was detected by western blotting, and PI3K activity was measured by Assay of PI3-K activity. Results Immunofluorescence staining showed that cultured fibroblasts derived from hypretrophic scars expressed both AT_1 and AT_2 receptors. Ang Ⅱ increased Akt phosphorylation and PI3K activity in cultured hypertrophic scar fibroblasts in a dose-and time-dependent manner. Additionally, Ang Ⅱ-induced Akt phosphorylation was blocked by wortmannin, a PI3-K inhibitor. This Ang Ⅱ-activated PI3-K/Akt cascade was significantly inhibited by valsartan, an AT_1 receptor specific blocker(P<0.05), whereas enhanced by PD123319, an AT_2 receptor antagonist (P< 0.05). Conclusion These results indicate that Ang Ⅱ receptors regulates PI3-K/Akt cascade of hypertrophic scars fibroblasts via AT_1 and AT_2.